Metzger Michael A sold SNDX
September 8, 2025 · Form 4 insider transaction
Metzger Michael A sold 157,307 shares of Syndax Pharmaceuticals, Inc. at $16.41 per share, a transaction worth $2.58M. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 0 days after the transaction.
Footnotes
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person solely covering equity grants with expiration dates prior to September 10, 2025. Following the sales reported in this Form 4, the Reporting Person has a total of 1,319,634 options to purchase shares of common stock that are vested and immediately exercisable and a total of 651,241 options to purchase shares of common stock that have not yet vested.; The sale prices ranged from $16.21 to $17.06.